» Articles » PMID: 24459135

Androgen Receptor Uses Relaxed Response Element Stringency for Selective Chromatin Binding and Transcriptional Regulation in Vivo

Overview
Specialty Biochemistry
Date 2014 Jan 25
PMID 24459135
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The DNA-binding domains (DBDs) of class I steroid receptors-androgen, glucocorticoid, progesterone and mineralocorticoid receptors-recognize a similar cis-element, an inverted repeat of 5'-AGAACA-3' with a 3-nt spacer. However, these receptors regulate transcription programs that are largely receptor-specific. To address the role of the DBD in and of itself in ensuring specificity of androgen receptor (AR) binding to chromatin in vivo, we used SPARKI knock-in mice whose AR DBD has the second zinc finger replaced by that of the glucocorticoid receptor. Comparison of AR-binding events in epididymides and prostates of wild-type (wt) and SPARKI mice revealed that AR achieves selective chromatin binding through a less stringent sequence requirement for the 3'-hexamer. In particular, a T at position 12 in the second hexamer is dispensable for wt AR but mandatory for SPARKI AR binding, and only a G at position 11 is highly conserved among wt AR-preferred response elements. Genome-wide AR-binding events agree with the respective transcriptome profiles, in that attenuated AR binding in SPARKI mouse epididymis correlates with blunted androgen response in vivo. Collectively, AR-selective actions in vivo rely on relaxed rather than increased stringency of cis-elements on chromatin. These elements are, in turn, poorly recognized by other class I steroid receptors.

Citing Articles

The Homeobox Transcription Factor NKX3.1 Displays an Oncogenic Role in Castration-Resistant Prostate Cancer Cells.

Budreika A, Phoenix J, Kostlan R, Deegan C, Ferrari M, Young K Cancers (Basel). 2025; 17(2.

PMID: 39858088 PMC: 11763476. DOI: 10.3390/cancers17020306.


Allosteric interactions prime androgen receptor dimerization and activation.

Wasmuth E, Vanden Broeck A, LaClair J, Hoover E, Lawrence K, Paknejad N Mol Cell. 2022; 82(11):2021-2031.e5.

PMID: 35447082 PMC: 9177810. DOI: 10.1016/j.molcel.2022.03.035.


The relationship between sexual dimorphism and androgen response element proliferation in primate genomes.

Anderson A, Jones A Evolution. 2022; 76(6):1331-1346.

PMID: 35420699 PMC: 9321733. DOI: 10.1111/evo.14483.


What Does Androgen Receptor Signaling Pathway in Sertoli Cells During Normal Spermatogenesis Tell Us?.

Wang J, Li Z, Yang W Front Endocrinol (Lausanne). 2022; 13:838858.

PMID: 35282467 PMC: 8908322. DOI: 10.3389/fendo.2022.838858.


The androgen receptor depends on ligand-binding domain dimerization for transcriptional activation.

El Kharraz S, Dubois V, van Royen M, Houtsmuller A, Pavlova E, Atanassova N EMBO Rep. 2021; 22(12):e52764.

PMID: 34661369 PMC: 8647150. DOI: 10.15252/embr.202152764.


References
1.
Pihlajamaa P, Sahu B, Lyly L, Aittomaki V, Hautaniemi S, Janne O . Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs. EMBO J. 2014; 33(4):312-26. PMC: 3989639. DOI: 10.1002/embj.201385895. View

2.
Liu T, Ortiz J, Taing L, Meyer C, Lee B, Zhang Y . Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol. 2011; 12(8):R83. PMC: 3245621. DOI: 10.1186/gb-2011-12-8-r83. View

3.
Shaffer P, Jivan A, Dollins D, Claessens F, Gewirth D . Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci U S A. 2004; 101(14):4758-63. PMC: 387321. DOI: 10.1073/pnas.0401123101. View

4.
Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A . Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J. 2011; 30(19):3962-76. PMC: 3209787. DOI: 10.1038/emboj.2011.328. View

5.
Gertz J, Savic D, Varley K, Partridge E, Safi A, Jain P . Distinct properties of cell-type-specific and shared transcription factor binding sites. Mol Cell. 2013; 52(1):25-36. PMC: 3811135. DOI: 10.1016/j.molcel.2013.08.037. View